, 10 mg de ?-sitostérol dont 0,1 mg de son ?-sitostérol?-D-glucoside/gélule ) avec une petite quantité de campestérol et de stigmastérol
, 58) ont réalisé en 1997 un nouvel essai multicentrique randomisé de 6 mois sur 177 patients testant l'Azurprostate® (?-sitostérol 130 mg + autres phytostérols issus du Pin et de l'Epicéa) contre un groupe Placebo
, 153) ont publié en 2002 une première étude multicentrique randomisée d'une année comparant l'efficacité de la tamsulosine 0,4mg (n=273) à celle du Permixon® 320mg
, 154) ont complété leurs travaux en publiant en 2004 l'étude PERMAL. Cet essai randomisé en double aveugle conduit sur un an a comparé le Permixon® (prise de 320mg/jour)
, Atlas d'anatomie Prométhée tome 2, Maloine, pp.256-263, 2007.
, Anatomie Physiologie Pathologie du corps humain, Maloine, pp.332-335
, Etude anatomique et comparative de la prostate de l'homme
, La prostate : une glande au carrefour uro-g??nital, Progr??s en Urologie, vol.22, pp.2-6, 2012.
DOI : 10.1016/S1166-7087(12)70028-3
, Lymphatiques de la prostate, traité d'anatomie humaine tome 2, pp.1211-1215, 1902.
, Hyperplasie bénigne de la prostate (HBP) : prévalence en médecine générale et attitude des médecins généralistes français. Résultats d'une étude réalisée auprès de 17953 patients, Prog. Urol, vol.14, pp.33-42, 2004.
, Diaporama Adénome de la prostate, Pôles cliniques Adénome de la prostate, www.urologie-mondor.fr (12) Inflammation et HBP : cause ou conséquence ?, Prog. Urol, vol.20, issue.6, pp.402-409, 2010.
, The Correlation Between Metabolic Syndrome and Prostatic Diseases, European Urology, vol.61, issue.3, pp.560-70, 2012.
DOI : 10.1016/j.eururo.2011.11.013
, Erectile dysfunction and lower urinary tract symptoms secondary to BPH, Eur Urol, vol.47, pp.838-883, 2005.
, Physical Activity and Benign Prostatic Hyperplasia, Archives of Internal Medicine, vol.158, issue.21, pp.2349-56, 1998.
DOI : 10.1001/archinte.158.21.2349
, Quantitative bacterial tissue cultures from 209 prostatectomy specimens : findings and implications, J.Urol, vol.139, pp.57-60, 1988.
, EVALUATION OF THE BACTERIAL FLORA OF THE PROSTATE USING A 16S rRNA GENE BASED POLYMERASE CHAIN REACTION, The Journal of Urology, vol.163, issue.1, pp.127-157, 2000.
DOI : 10.1016/S0022-5347(05)67987-6
, PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome, The Prostate, vol.63, issue.1, pp.49-54, 2000.
DOI : 10.1002/1097-0045(20000615)44:1<49::AID-PROS7>3.0.CO;2-7
, Cytokine Expression Pattern in Benign Prostatic Hyperplasia Infiltrating T Cells and Impact of Lymphocytic Infiltration on Cytokine mRNA Profile in Prostatic Tissue, Laboratory Investigation, vol.103, issue.8, pp.1131-1177, 2003.
DOI : 10.1016/0167-5699(94)90021-3
, Répercussions de l'hypertrophie bénigne de la prostate sur le confort de vie des patients, Prog.Urol, vol.7, pp.63-68, 1997.
, Dysfonction ??rectile et hyperplasie b??nigne de la prostate??: deux pathologies fr??quentes de l???homme ??g??, Progr??s en Urologie - FMC, vol.22, issue.3, pp.1-5, 2012.
DOI : 10.1016/j.fpurol.2012.05.001
, Accréditation et d'Evaluation en Santé, Recommandations pour la pratique clinique-Prise en charge diagnostique et thérapeutique de l'hypertrophie bénigne de la prostate, 2003.
, La prostate, symbole de la vulnérabilité masculine : une enquête qualitative AFU-IPSOS, Prog.Urol, vol.16, pp.324-331, 2006.
DOI : 10.1016/s1166-7087(07)92263-0
, Perceptions de l???hypertrophie b??nigne de la prostate par le patient et le m??decin g??n??raliste?????????tude Troph??e, Progr??s en Urologie, vol.23, issue.1, pp.50-57, 2013.
DOI : 10.1016/j.purol.2012.10.003
, Troubles sexuels associ??s aux maladies de la prostate, Progr??s en Urologie, vol.22, pp.514-534, 2012.
DOI : 10.1016/S1166-7087(12)70030-1
, Bilan initial, suivi et traitement des troubles mictionnels en rapport avec hyperplasie b??nigne de prostate??: recommandations du CTMH de l???AFU, Progr??s en Urologie, vol.22, issue.16, pp.977-88, 2012.
DOI : 10.1016/j.purol.2012.10.001
, Management of non-complicated BPH : proposition of a renewed decision tree, World J.Urol, issue.27, 2006.
, Prise en charge des sympt??mes du bas appareil urinaires li??s ?? l???hypertrophie b??nigne de prostate, Progr??s en Urologie, vol.24, issue.14, pp.929-962, 2014.
DOI : 10.1016/j.purol.2014.07.010
, Effet de l'environnement et de l'alimentation sur l'hypertrophie bénigne de la prostate et les troubles mictionnels-interview, 2001.
, Conseil à un patient prostatique-suivi officinal, Actualités pharmaceutiques n° 498, 2010.
, les nouveautés médicamenteuses dans l'hypertrophie bénigne de la prostate, Prog.Urol, vol.24, pp.13-16, 2014.
, Guide pratique des médicaments Dorosz, Maloine, 36 ème édition, 2017.
, Effets n??gatifs sur la sexualit?? des traitements m??dicamenteux des sympt??mes du bas appareil urinaire li??s a l???hypertrophie b??nigne de la prostate, Progr??s en Urologie, vol.25, issue.3, pp.115-127, 2015.
DOI : 10.1016/j.purol.2014.12.003
, Le guide-Médicaments et iatrogénèse, Lavoisier Médecine Sciences, pp.234-280
, Incidence et profil des patients avec hyperplasie b??nigne de la prostate (HBP) symptomatique, pour lesquels les urologues instaurent une bith??rapie, Progr??s en Urologie - FMC, vol.19, issue.1, 2009.
DOI : 10.1016/S1761-676X(09)70030-6
, Traitement m??dical de l???hyperplasie b??nigne de prostate, Progr??s en Urologie, vol.19, issue.12, pp.890-92, 2009.
DOI : 10.1016/j.purol.2009.09.006
, What do we know about phytotherapy of benign prostatic hyperplasia?, Life Sciences, vol.126, pp.42-56, 2015.
DOI : 10.1016/j.lfs.2015.01.023
, Effets des inhibiteurs de la phosphodiest??rase de type 5??sur les sympt??mes du bas appareil urinaire associ??s ?? une hypertrophie b??nigne de la prostate, Progr??s en Urologie, vol.23, issue.5, pp.283-95, 2013.
DOI : 10.1016/j.purol.2012.11.009
, Toxines botuliques : applications urologiques, Prog Urol, vol.16, pp.263-74, 2006.
, Traitements chirurgicaux de l???hypertrophie b??nigne de la prostate, Progr??s en Urologie, vol.19, issue.4, pp.274-282, 2009.
DOI : 10.1016/j.purol.2008.10.031
, Phytotherapy for benign prostatic hyperplasia, Public Health Nutrition, vol.4, issue.4a, pp.459-72
DOI : 10.1002/(SICI)1097-0045(199610)29:43.0.CO;2-E
, The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia, World Journal of Urology, vol.19, issue.6, pp.426-461, 2002.
DOI : 10.1007/s00345-002-0247-6
, Extracts from Fruits of Saw Palmetto (Sabal serrulata) and Roots of Stinging Nettle (Urtica dioica): Viable Alternatives in the Medical Treatment of Benign Prostatic Hyperplasia and Associated Lower Urinary Tracts Symptoms, Planta Medica, vol.67, issue.6, pp.489-500, 2001.
DOI : 10.1055/s-2001-16496
, Phytotherapy of Benign Prostatic Hyperplasia. A Minireview, Phytotherapy Research, vol.18, issue.7, pp.949-55, 2014.
DOI : 10.1002/ptr.5084
, Saw Palmetto Extracts for Treatment of Benign Prostatic Hyperplasia, JAMA, vol.280, issue.18, pp.1604-1613, 1998.
DOI : 10.1001/jama.280.18.1604
, Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia, Urology, vol.55, issue.4, pp.533-542, 2000.
DOI : 10.1016/S0090-4295(99)00593-2
, Phytotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia, The Journal of Urology, vol.179, issue.6, pp.2119-2144, 2008.
DOI : 10.1016/j.juro.2008.01.094
, Pygeum africanum for benign prostatic hyperplasia-review, Cochrane Database of systematic reviews, p.1044, 1998.
, Phytotherapy in the management of benign prostatic hyperplasia, Urology, vol.58, issue.6, 2001.
DOI : 10.1016/S0090-4295(01)01303-6
, Efficacy of pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia : evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study, pp.102-667, 1990.
, Efficacy and Acceptability of Tadenan??(Pygeum africanum Extract) in the Treatment of Benign Prostatic Hyperplasia (BPH): A Multicentre Trial in Central Europe, Current Medical Research and Opinion, vol.14, issue.3, pp.127-166, 1998.
DOI : 10.1185/03007999809113352
, Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: a randomized, double-blind study, with long-term open label extension, Urology, vol.54, issue.3, pp.473-481, 1999.
DOI : 10.1016/S0090-4295(99)00147-8
, L'ortie dioïque-fiche phytothérapie, Actualités pharmaceutiques, n°490, pp.53-58, 2009.
, Physiologie des androgènes chez l'homme adulte, Prog Urol, p.639, 2004.
, Estradiol causes the rapid accumulation of cAMP in human prostate., Proc.Natl.Acad.Sci, USA 91, pp.5402-5407, 1994.
DOI : 10.1073/pnas.91.12.5402
, on the Interaction of SHBG with its Receptor on Human Prostatic Membranes, Planta Medica, vol.61, issue.01, pp.31-33, 1995.
DOI : 10.1055/s-2006-957993
, and their Metabolites Bind to Human Sex Hormone Binding Globulin (SHBG), Planta Medica, vol.63, issue.06, pp.529-561, 1997.
DOI : 10.1055/s-2006-957756
, A comprehensive review on the stinging nettle effect and efficacy profiles, pp.568-79, 2007.
, Inhibition of 5 ?-reductase and aromatase by PHL-00801 (Prostatonin®), a combination of PY 102 (Pygeum africanum) and UR 102 (Urtica dioica) extracts, pp.121-129, 1996.
, Ameliorative effects of stinging nettle (Urtica dioica) on testosteroneinduced prostatic hyperplasia in rats, Andrologia, vol.201244, issue.72, pp.396-409
, The histological and histometrical effects of Urtica dioica extract on rat's prostate hyperplasia, Veterinary Research Forum, vol.6, issue.1, pp.23-32, 2015.
, Aromatase inhibitors from Urtica dioica roots, Planta Med, 1995.
, Search for the antiprostatic principle of stinging nettle (Urtica dioica) roots, Phytomedicine, vol.1, issue.3, pp.213-237, 1994.
DOI : 10.1016/S0944-7113(11)80068-1
, Antiproliferative Effect on Human Prostate Cancer Cells by a Stinging Nettle Root (Urtica dioica) Extract, Planta Medica, vol.66, issue.1, pp.44-51, 2000.
DOI : 10.1055/s-2000-11117
, Root Extracts on Experimentally Induced Prostatic Hyperplasia in the Mouse, Planta Medica, vol.63, issue.04, pp.307-317, 1997.
DOI : 10.1055/s-2006-957688
, Stinging nettle roots extract (Bazoton-Uno) in long term treatment of benign prostatic syndrom (BPS) Results of a randomized double-blind, placebo-controlled muticenter study after 12 months, Urologe (A), vol.43, pp.302-308, 2004.
, Urtica dioica for treatment of Benign Prostatic Hyperplasia : a prospective, randomized, double-blind, placebo-controlled, crossover study, Journal of Herbal Pharmacotherapy, vol.5, issue.4, 2005.
, The Efficacy of Stinging Nettle (Urtica Dioica) in Patients with Benign Prostatic Hyperplasia: A Randomized Double-Blind Study in 100 Patients, Iranian Red Crescent Medical Journal, vol.15, issue.1, 2013.
DOI : 10.5812/ircmj.2386
, Cucurbita pepo L. (Cucurbitaceae) Graine de courge ou citrouille, Graine de courge ou citrouille, pp.46-51, 2013.
DOI : 10.1007/s10298-013-0754-1
, The role of Cucurbita pepo in the management of patients affected by lower urinary tract symptoms due to benign prostatic hyperplasia : a narrative review, Archivo Italiano di urologia e, Andrologia, vol.88, issue.2, 2016.
, Chemical composition and functional characterisation of commercial pumpkin seed oil, Journal of the Science of Food and Agriculture, vol.15, issue.5, pp.1035-1076, 2013.
DOI : 10.1002/jsfa.5843
, Pumpkin seed extract: Cell growth inhibition of hyperplastic and cancer cells, independent of steroid hormone receptors, Fitoterapia, vol.110, pp.150-156, 2016.
DOI : 10.1016/j.fitote.2016.03.010
, Seeds and oil of the Styrian oil pumpkin: Components and biological activities, European Journal of Lipid Science and Technology, vol.97, issue.11, pp.1128-1168, 2007.
DOI : 10.1002/ejlt.200700105
, A review of animal and studies for management of benign prostatic hyperplasia with natural products : perspective of new pharmacological agents, Inflammation and Allergy-Drug Targets, pp.207-228, 2012.
, Pumpkin Seed Oil and Phytosterol-F Can Block Testosterone/Prazosin-Induced Prostate Growth in Rats, Urologia Internationalis, vol.77, issue.3, pp.269-74, 2006.
DOI : 10.1159/000094821
, Effect of pumpkin-seed oil on the level of free radical scavengers induced during adjuvant-artthritis in rats, 1995.
, Antioxidant and lipoxygenase inhibitory activities of pumpkin seed extracts, Food Research International, vol.42, issue.5-6, pp.641-646, 2009.
DOI : 10.1016/j.foodres.2009.02.003
, Effect of the extracts of pumpkin seeds on the urodynamics of rabbits : an experimental study, Journal of Tongji Medical University, vol.14, issue.4, pp.235-243, 1994.
, Experience with the Peponen?? capsule in the management of benign prostatic hyperplasia, International Urology and Nephrology, vol.27, issue.1, pp.51-56, 1991.
DOI : 10.1007/BF02549728
, Prosta Fink Forte capsules in the treatment of benign prostatic hyperplasia. Multicentric surveillance study in 2245 patients, 2000.
, Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia, Nutrition Research and Practice, vol.3, issue.4, pp.323-330, 2009.
DOI : 10.4162/nrp.2009.3.4.323
, Effects of Pumpkin Seed in Men with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia in the One-Year, Randomized, Placebo-Controlled GRANU Study, Urologia Internationalis, vol.94, issue.3, pp.286-95, 2005.
DOI : 10.1159/000362903
, Phytochemistry, pharmacology and traditional uses of different Epilobium species (Onagraceae): A review, Journal of Ethnopharmacology, vol.156, pp.316-362, 2014.
DOI : 10.1016/j.jep.2014.08.036
, Anti-proliferative effect on a prostatic epithelial cell line (PZ-HPV-7) by Epilobium angustifolium L., Il Farmaco, vol.56, issue.5-7, pp.483-492, 2001.
DOI : 10.1016/S0014-827X(01)01067-9
, Les effets pharmacologiques d'extraits d'Epilobium, Phytothérapie, pp.150-152, 2008.
DOI : 10.1007/s10298-008-0320-4
, L.) Extracts, Journal of Agricultural and Food Chemistry, vol.54, issue.10, pp.3617-3641, 2006.
DOI : 10.1021/jf052606i
, Studies of Epilobium angustifolium extracts on growth of accessory sexual organs in rats, Journal of Ethnopharmacology, vol.55, issue.3, pp.179-83, 1997.
DOI : 10.1016/S0378-8741(96)01498-5
, inhibit proliferation of human prostate cells, Journal of Pharmacy and Pharmacology, vol.157, issue.5, pp.683-90, 2003.
DOI : 10.1211/002235703765344603
, Influence of epilobium extracts on prostaglandin biosynthesis and carrageenin induced oedema of the rat paw, Journal of Ethnopharmacology, vol.17, issue.2, pp.161-170, 1986.
DOI : 10.1016/0378-8741(86)90055-3
, Anti-inflammatory effects of a substance extracted from Epilobium angustifolium, Agents and Actions, vol.51, issue.1-2, pp.1-2, 1988.
DOI : 10.1007/BF01967206
, Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp, Phytomedicine, vol.18, issue.7, pp.557-560, 2011.
DOI : 10.1016/j.phymed.2010.10.016
, Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis, Journal of Ethnopharmacology, vol.103, issue.1, pp.71-75, 2006.
DOI : 10.1016/j.jep.2005.07.007
, Schreb., Phytotherapy Research, vol.8, issue.5, pp.719-743, 2009.
DOI : 10.1002/ptr.2725
, Immunomodulatory Activity of Oenothein B Isolated from Epilobium angustifolium, The Journal of Immunology, vol.183, issue.10, pp.6754-66, 2009.
DOI : 10.4049/jimmunol.0901827
, Analgesic properties of Epilobium angustifolium, evaluated by the hot plate test and the writhing test, Il Farmaco, vol.56, issue.5-7, pp.341-344, 2001.
DOI : 10.1016/S0014-827X(01)01046-1
, Antinociceptive activity of methanolic extract of Epilobium hirsutum, Pak J Biol Sci, vol.10, issue.16, pp.2764-2771, 2007.
, Antimicrobial activity of Epilobium spp. extracts, Il Farmaco, vol.56, issue.5-7, pp.345-353, 2001.
DOI : 10.1016/S0014-827X(01)01047-3
, Antinociceptive, anti-inflammatory and antidiabetic properties of Hypoxis hemerocallidea Fisch. & C.A. Mey. (Hypoxidaceae) corm [???African Potato???] aqueous extract in mice and rats, Journal of Ethnopharmacology, vol.103, issue.1, pp.126-160, 2006.
DOI : 10.1016/j.jep.2005.07.012
, corm): a plant-medicine for modern and 21st century diseases of mankind? - a review, Phytotherapy Research, vol.30, issue.2, pp.147-52, 2009.
DOI : 10.1002/ptr.2595
, ), Journal of Agricultural and Food Chemistry, vol.55, issue.5, pp.1707-1718, 2007.
DOI : 10.1021/jf0619838
, Alternative medications for benign prostatic hyperplasia available on the Internet: a review of the evidence for their use, BJU International, vol.34, issue.1, pp.41-45, 2002.
DOI : 10.1046/j.1464-410X.2002.02771.x
, Randomised, placebo-controlled, double-blind clinical trial of ?-sitosterol in patients with benign prostatic hyperplasia, The Lancet, pp.1529-1561, 1995.
, Treatment of symptomatic benign prostatic hyperplasia with ??-sitosterol: an 18-month follow-up, BJU International, vol.338, issue.7, pp.842-848, 2000.
DOI : 10.1046/j.1464-410x.2000.00672.x
, Doxazosin Treatment in Patients with Prostatic Obstruction, Scandinavian Journal of Urology and Nephrology, vol.116, issue.1, pp.39-44, 1993.
DOI : 10.3109/00365599309180412
, Alfuzosin for treatment of benign prostatic hypertrophy. The BPH-ALF group, The Lancet, pp.1457-61, 1991.
, A double-blind trial of the effect of ?-sitosteryl glucoside (WA 184) in the treatment of benign prostatic hyperplasia, Eur. Urol, vol.12, pp.187-196, 1986.
, Conservative treatment of benign prostatic hyperplasia with high-dosage ?sitosterol : results of a placebo-controlled, double blind study, pp.12-20, 1993.
, Cytokine production in human and rat macrophages and dicatechol rooperol and esters, Biochemical Pharmacology, vol.52, issue.7, pp.991-999, 1996.
DOI : 10.1016/0006-2952(96)00386-3
, Prostaglandin inhibitory activity by lectin-like proteins from South African medicinal plants, South African Journal of Botany, vol.72, issue.4, pp.661-664, 2006.
DOI : 10.1016/j.sajb.2006.02.005
URL : http://dx.doi.org/10.1016/j.sajb.2006.02.005
, Role of membranes on the antibacterial and anti-inflammatory activities of the bioactive compounds from Hypoxis rooperi corm extract, Archives of Biochemistry and Biophysics, vol.467, issue.1, pp.119-150, 2007.
DOI : 10.1016/j.abb.2007.08.013
, Interaction of lectin-like proteins of South African medicinal plants with Staphylococcus aureus and Bacillus subtilis, Journal of Ethnopharmacology, vol.80, issue.2-3, pp.131-136, 2002.
DOI : 10.1016/S0378-8741(02)00011-9
, Wirksamkeit eines Sabal-Urtica-kombinationspräpar ats bei der Behandlung der benigner prostata hyperplasie (BPH), pp.292-300, 1996.
DOI : 10.1007/s001310050033
, Combined Sabal and Urtica extract vs finasteride in BPH (Alken stage I???II), Der Urologe, vol.36, issue.4, pp.327-360, 1997.
DOI : 10.1007/s001200050106
, Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome, BJU International, vol.28, issue.4, pp.439-481, 2006.
DOI : 10.1056/NEJM199802263380909
, Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms???a placebo-controlled, double-blind, multicenter trial, World Journal of Urology, vol.280, issue.2, pp.139-185, 2005.
DOI : 10.1007/s00345-005-0501-9
, A Meta-Analysis on the Efficacy and Tolerability of α<sub>1</sub>-Adrenoceptor Antagonists in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction, European Urology, vol.36, issue.1, pp.1-13, 1999.
DOI : 10.1159/000019919
, The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia, New England Journal of Medicine, vol.338, issue.9, pp.557-63, 1998.
DOI : 10.1056/NEJM199802263380901
, Long-term clinical and biologic effects of the lipidosterolic extract ofSerenoa repens in patients with symptomatic benign prostatic hyperplasia, Advances in Therapy, vol.36, issue.4, pp.297-306, 2002.
DOI : 10.1007/BF02853175
, Long-Term Effects of Finasteride in Patients with Benign Prostatic Hyperplasia: A Double-Blind, Placebo-Controlled, Multicenter Study, Urology, vol.51, issue.5, pp.677-86, 1998.
DOI : 10.1016/S0090-4295(98)00094-6
, Long-term efficacy and safety of PRO 160/120 (a combination of Sabal and Urtica extract) in patients with lower urinary tract symptoms (LUTS), Phytomedicine, vol.10, issue.4, pp.53-55, 2003.
DOI : 10.1078/1433-187X-00352
, Combined extracts of Urtica dioica and Pygeum africanum in the treatment of benig prostatic hyperplasia : double-blind comparison of two doses, Clin Ther, vol.15, issue.6, pp.1011-1031, 1993.
, Evaluating the efficiency of a combination of Pygeum africanum and Stinging nettle (Urtica dioica) extracts in treating benign prostatic hyperplasia (BPH) : doubleblind , randomized, placebo-controlled trial, International Braz J. Urol, vol.28, issue.5, pp.418-443, 2002.
, Treatment by curbicin in benign prostatic hyperplasia (BPH)
, Treatment of Benign Prostatic Hyperplasia with Phytosterols, British Journal of Urology, vol.20, issue.6, pp.639-680, 1990.
DOI : 10.1111/j.1464-410X.1990.tb07199.x
, A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: A herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy, Complementary Therapies in Medicine, vol.21, issue.3, pp.172-79, 2013.
DOI : 10.1016/j.ctim.2013.01.007
, Effect of Saw Palmetto Soft Gel Capsule on Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Randomized Trial in Shanghai, China, The Journal of Urology, vol.179, issue.2, pp.610-615, 2008.
DOI : 10.1016/j.juro.2007.09.032
, Associating Serenoa repens, Urtica dioica and Pinus pinatser. Safety and efficacy in the treatment of lower urinary tract symptoms. Prospective study on 320 patients, Urologia, vol.77, issue.1, pp.43-51, 2010.
, Analysis of the results obtained with a new phytotherapeutic association for benign prostatic hyperplasia versus control, Urologia, vol.77, issue.3, pp.180-186, 2010.
, Treatment of chronic prostatitis/ chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenemiun and lycopene (PROFLUSS) versus Sereneoa repens alone : an italian randomized multicenter-controlled study, pp.400-406, 2010.
, Comparion of phytotherapy ( Permixon®) with finasteride in the treatment of benign prostate hyperplasia : a randomized international study of 1098 patients, The Prostate, pp.231-271, 1996.
, Tamsulosine avec ou sans Serenoa repens dans l'hypertrophie bénigne de la prostate : l'essai OCOS, Prog Urol, vol.12, pp.395-403, 2002.
, Comparison of Tamsulosin Plus Serenoa Repens with Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Korean Men: 1-Year Randomized Open Label Study, Urologia Internationalis, vol.94, issue.2, pp.187-93, 2015.
DOI : 10.1159/000366521
, Comparison of a Phytotherapeutic Agent (Permixon) with an ??-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: A 1-Year Randomized International Study, European Urology, vol.41, issue.5, pp.497-507, 2002.
DOI : 10.1016/S0302-2838(02)00066-0
, Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients???PERMAL Study Subset Analysis, European Urology, vol.45, issue.6, pp.773-80, 2004.
DOI : 10.1016/j.eururo.2004.01.015
, A prospective study of the efficacy of Serenoa repens, Tamsulosin, and Serenoa repens plus Tamsulosin treatment for patients with benign prostate hyperplasia, International Urology and Nephrology, vol.127, issue.2, pp.879-86, 2007.
DOI : 10.1007/s11255-006-9106-5
, Pumpkin seed oil (Prostafit ®) or prazosin ? Which one is better in the treatment of symptomatic benign prostatic hyperplasia, J. Pack Med Assoc, vol.64, issue.6, pp.683-688, 2014.
, Evaluation of Male Sexual Function in Patients with Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) Treated with a Phytotherapeutic Agent (Permixon??), Tamsulosin or Finasteride, European Urology, vol.48, issue.2, pp.269-76, 2005.
DOI : 10.1016/j.eururo.2005.03.029
, Comparaison of differents drugs on the treatment of benign prostatic hyperplasia, Zhonghua Wai Ke Za Zhi, vol.45, issue.14, pp.947-50, 2007.
, Lignans and isoflavonoids in plasma and prostatic fluid in men: Samples from Portugal, Hong Kong, and the United Kingdom, Hong Kong, and the United Kingdom, pp.122-128
DOI : 10.1002/(SICI)1097-0045(19970701)32:2<122::AID-PROS7>3.0.CO;2-O
, Isoflavones in Treating Watchful Waiting Benign Prostate Hyperplasia: A Double-Blinded, Randomized Controlled Trial, The Journal of Alternative and Complementary Medicine, vol.18, issue.1, pp.54-60, 2014.
DOI : 10.1089/acm.2010.0077